Procter & Gamble Health Ltd - 500126 - Communication With Respect To Tax Deducted At Source On Dividend Income Declared By The Company
Board of Directors of the Company at its Meeting held on February 05, 2023, have declared an Interim dividend of Rs. 45 per equity share of face value of Rs. 10 each for Company's Financial Year 2022-23. In accordance with the provisions of the Income Tax Act, 1961 as amended by and read with the provisions of the Indian Finance Act, 2020, dividend declared and paid by the Company after April 1, 2020, is taxable in the hands of shareholders and the Company is required to deduct the tax at source ('TDS') on the distribution of dividend income to its shareholders at the applicable rates. Accordingly, shareholders are requested to furnish requisite details to enable the Company to determine the appropriate TDS rate (if any).07-02-2023